Lv1
40 积分 2023-11-29 加入
Etrasimod for the treatment of ulcerative colitis
2天前
已完结
Proinflammatory phenotype in major depressive disorder with adulthood adversity: In line with social signal transduction theory of depression
3个月前
已完结
The Potential of KCNQ Potassium Channel Openers as Novel Antidepressants
3个月前
已完结
The role of KCNQ channel activators in management of major depressive disorder
4个月前
已完结
A controlled trial of rasagiline in early Parkinson disease: The tempo study
5个月前
已完结
Clinical investigations of compounds targeting metabotropic glutamate receptors
6个月前
已完结
TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond
6个月前
已完结
A phase 2b, Randomized, double blinded comparison of the safety and efficacy of the monoclonal antibody mixture SYN023 and human rabies immune globulin in patients exposed to rabies
6个月前
已完结
ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension
7个月前
已完结
Obefazimod: A First-in-class Drug for the Treatment of Ulcerative Colitis
7个月前
已完结
皖公网安备34019202002308
